Treatment of ACVR1-mediated diseases
Abstract:
Provided herein are methods, compositions, and kits for treating ACVR-1-mediated diseases using N-(cyanomethyl)-4-[2-4-morpholinoanilino)pyrimidin-4-yl]benzamide.
Public/Granted literature
Information query
Patent Agency Ranking
0/0